Periwinkle

Taxonomy

Periwinkle (Vinca minor) is a flowering plant belonging to the kingdom Plantae, division Magnoliophyta, class Liliopsida, order Apocynales, family Apocynaceae, genus Vinca, and species Vinca minor.

The following table shows the full taxonomy of this plant.

Morphology

Periwinkle (Vinca minor) is a low-growing evergreen perennial with spreading, trailing stems that root at the nodes, forming dense mats of foliage and producing clusters of blue-violet flowers in late spring.

Distribution

Periwinkle (Vinca minor) is native to Europe, western Asia, and northern Africa, and is commonly found in woodlands, rocky soils, and shaded areas across these regions.

Traditional Uses

Periwinkle (Vinca minor) has been traditionally used in herbal medicine for its purported ability to treat wounds, promote circulation, and alleviate symptoms of certain skin conditions.

Medicinal Systems

In traditional medicinal systems such as Ayurveda, Traditional Chinese Medicine, and Native American healing practices, Periwinkle (Vinca minor) has been utilized for its purported therapeutic properties.

Phytochemistry

Periwinkle (Vinca minor) contains alkaloids such as vincamine, vincadifformin, and catharanthine, which contribute to its pharmacological properties and traditional use in herbal medicine.

Pharmacology

Periwinkle (Vinca minor) exhibits pharmacological properties characterized by its ability to enhance cognitive function, support cardiovascular health, and demonstrate antimicrobial and anti-inflammatory effects.

Medicinal Uses

Periwinkle is used to treat conditions such as hypertension, diabetes, leukemia, and various skin disorders.

Preparations

Periwinkle is used to prepare various herbal formulations, including tinctures, teas, and topical salves, often utilized for their potential medicinal properties in traditional and alternative medicine practices.

Safety

While Periwinkle (Vinca minor) is generally considered safe when used in recommended doses, it may cause gastrointestinal discomfort, skin irritation, and in some cases, allergic reactions, particularly in individuals with a history of sensitivity to related plants.

Evidence

Clinical evidence for Periwinkle (Vinca minor) primarily supports its use in the treatment of leukemia, with some studies suggesting that its alkaloids, such as vincristine and vinblastine, may inhibit cancer cell growth by disrupting microtubule formation.

Cultivation

Periwinkle (Vinca minor) is typically cultivated in shaded, moist soils with well-drained conditions, preferring partial to full shade and thriving in USDA hardiness zones 4 to 8.

Processing

Processing Periwinkle (Vinca minor) involves harvesting the above-ground parts of the plant during early summer when the foliage is most abundant, followed by drying the material in a shaded, well-ventilated area to preserve its active compounds.

Identification

Periwinkle (Vinca minor) is a low-growing evergreen perennial plant identified by its dark green, glossy leaves and clusters of blue-purple flowers that bloom in spring, typically from April to June.

Sustainability

Vinca minor is considered sustainable in herbal medicine due to its rapid growth, ability to thrive in shaded environments, and minimal need for chemical inputs, making it a resilient and eco-friendly plant for cultivation and use.

Related

Vinca major, also known as greater periwinkle, is a related species that shares similar medicinal properties with Vinca minor and is also used in traditional herbal medicine for its anti-inflammatory and antitumor effects.

Research Gap

Current research on Periwinkle (Vinca minor) in herbal medicine is limited, with most studies focusing on its alkaloid content and limited pharmacological applications, leaving significant gaps in understanding its full therapeutic potential, traditional uses, and safety profile.

References

1. Szostak, Kowalewski. "The flavonoids in the leaves of Vinca minor L. (Apocynaceae)." Polish journal of pharmacology and pharmacy
2. Farahanikia, Akbarzadeh, Jahangirzadeh, Yassa, Shams Ardekani, Mirnezami, Hadjiakhoondi, Khanavi. "Phytochemical Investigation of Vinca minor Cultivated in Iran." Iranian journal of pharmaceutical research : IJPR
3. Khanavi, Pourmoslemi, Farahanikia, Hadjiakhoondi, Ostad. "Cytotoxicity of Vinca minor." Pharmaceutical biology
4. Mai, Richardson, Mann, Greene, Paul, Perley, Deslongchamps, Qu. "Promiscuous and regiospecific Vinca minor hydroxylases for opioid akuammine biosynthesis and monoterpenoid indole alkaloid diversification." Plant physiology and biochemistry : PPB